Mottola Frank bought SUPN
August 12, 2026 · Form 4 insider transaction
Mottola Frank bought 1,650 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,650
Price
$0.00
Total value
N/A
InsiderMottola Frank
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 12, 2026
Filing dateAugust 14, 2026
Shares owned after20,341
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.